PerkinElmer Acquires Prenatal, Newborn Screening Laboratory In India

PerkinElmer has acquired the genetic screening business of Surendra Genetic Labs, a laboratory in India that focuses on fetal, maternal and newborn health.

Ann-Christine Sundell, president, Genetic Screening, PerkinElmer, said: “The acquisition of Surendra Labs is a key component of PerkinElmer’s global commitment to facilitate access to advanced fetal, maternal and child health screening and diagnostic technologies and services for the Indian public and clinicians. This will enable PerkinElmer to extend our offerings to ensure better health outcomes in pregnancy and of newborns, as well as introduce new technologies to the India market.”

Dr S Suresh, director, Surendra Labs, said: “In partnership with PerkinElmer, we look forward to increasing the availability of screening services throughout the country, via a successful combination of local infrastructure and global technologies and expertise.”

Surendra Genetics Labs is based in Chennai, India and is providing testing services for pregnant mothers and newborns.

PerkinElmer’s Genetic Screening business is a clinical genetics and diagnostics, with products in clinical screening, cytogenetics, maternal and fetal health monitoring, and newborn screening.